{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:47:27Z","timestamp":1777945647979,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.annpat.2025.06.025","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:15:31Z","timestamp":1755616531000},"page":"178-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tour d\u2019horizon actualis\u00e9 de la pathologie des tumeurs neuroblastiques p\u00e9riph\u00e9riques"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0655-9281","authenticated-orcid":false,"given":"C.","family":"Gengler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Boudjemaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2808-3894","authenticated-orcid":false,"given":"A.","family":"Gazeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3183-0125","authenticated-orcid":false,"given":"H.","family":"Sartelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2025.06.025_bib0295","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cncr.28748","article-title":"Declining childhood and adolescent cancer mortality","volume":"120","author":"Smith","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1245-1789(23)47450-1","article-title":"Neuroblastoma","volume":"58","author":"Plantaz","year":"2023","journal-title":"EMC Pediatr"},{"key":"10.1016\/j.annpat.2025.06.025_bib0305","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/1078-0432.CCR-24-0237","article-title":"Neuroblastoma predisposition and surveillance-an update from the 2023\u00a0AACR Childhood Cancer Predisposition Workshop","volume":"30","author":"Kamihara","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2025.06.025_bib0310","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-017-2747-0","article-title":"Neuroblastoma pathogenesis: deregulation of embryonic neural crest development","volume":"372","author":"Tomolonis","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.annpat.2025.06.025_bib0315","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent Advances in Neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2025.06.025_bib0320","first-page":"510","article-title":"La cr\u00eate neurale embryonnaire construit notre identit\u00e9 faciale\u00a0: le visage des vert\u00e9br\u00e9s","volume":"35","author":"Couly","year":"2019","journal-title":"Med Sci"},{"key":"10.1016\/j.annpat.2025.06.025_bib0325","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.bjc.6600231","article-title":"Experience with International Neuroblastoma Staging System and Pathology Classification","volume":"86","author":"Ikeda","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0330","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1200\/JCO.2014.56.1621","article-title":"Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project","volume":"32","author":"Vo","year":"2014","journal-title":"J Am Soc Clin Oncol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0335","series-title":"Canc\u00e9rologie de l\u2019enfant","author":"Perel","year":"2017"},{"key":"10.1016\/j.annpat.2025.06.025_bib0340","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00259-017-3829-7","article-title":"Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN\/HR-NBL1\u00a0and COG-A3973\u00a0trials","volume":"45","author":"Ladenstein","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.annpat.2025.06.025_bib0345","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y","article-title":"Terminology and morphologic criteria of neuroblastic tumors","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0350","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0242-6498(04)94018-7","article-title":"Peripheral neuroblastic tumors: anatomo pathological classification","volume":"24","author":"Peuchmaur","year":"2004","journal-title":"Ann Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0355","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/pbc.24238","article-title":"Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee","volume":"60","author":"Suganuma","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0360","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/pin.13085","article-title":"Biological categories of neuroblastoma based on the international neuroblastoma pathology classification for treatment stratification","volume":"71","author":"Nakazawa","year":"2021","journal-title":"Pathol Int"},{"key":"10.1016\/j.annpat.2025.06.025_bib0365","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/cup.12192","article-title":"Rosette-like structures in the spectrum of spitzoid tumors","volume":"40","author":"Arps","year":"2013","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0370","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The International Neuroblastoma Pathology Classification (the Shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0375","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1582::AID-CNCR24>3.0.CO;2-V","article-title":"Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. A clinicopathologic study of 223\u00a0cases from the Pediatric Oncology Group","volume":"77","author":"Joshi","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0380","doi-asserted-by":"crossref","first-page":"874","DOI":"10.5858\/2005-129-874-PFTEOS","article-title":"Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors","volume":"129","author":"Qualman","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.annpat.2025.06.025_bib0385","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jnci\/73.2.405","article-title":"Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas","volume":"73","author":"Shimada","year":"1984","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annpat.2025.06.025_bib0390","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/cncr.11773","article-title":"Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular","volume":"98","author":"Peuchmaur","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0395","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S","article-title":"International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors","volume":"92","author":"Shimada","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0400","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00428-006-0253-y","article-title":"Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182\u00a0cases from the Spanish Neuroblastoma Registry","volume":"449","author":"Burgues","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.annpat.2025.06.025_bib0405","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/1097-0142(20000901)89:5<1150::AID-CNCR25>3.0.CO;2-7","article-title":"Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular","volume":"89","author":"Umehara","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0410","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/PAS.0b013e31825a6895","article-title":"PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors","volume":"36","author":"Bielle","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0415","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/PAS.0b013e318289c765","article-title":"A study of gata3\u00a0and phox2b expression in tumors of the autonomic nervous system","volume":"37","author":"Nonaka","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0420","first-page":"471","article-title":"[Diagnostic utility of tyrosine hydroxylase in peripheral neuroblastic tumors]","volume":"46","author":"Zhang","year":"2017","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.annpat.2025.06.025_bib0425","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2350\/15-07-1676-OA.1","article-title":"Improving detection of metastatic neuroblastoma in bone marrow core biopsies: a proposed immunohistochemical approach","volume":"19","author":"Parsons","year":"2016","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0430","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1093526616686253","article-title":"An evidence-based recommendation for a standardized approach to detecting metastatic neuroblastoma in staging bone marrow biopsies","volume":"20","author":"Parsons","year":"2017","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0435","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/10668969231177700","article-title":"Diagnostic utility of GATA3\u00a0and ISL1\u00a0in differentiating neuroblastoma from other pediatric malignant small round blue cell tumors","volume":"32","author":"Mohanty","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0440","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cncr.30380","article-title":"Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group","volume":"123","author":"Burchill","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0445","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/bjc.2015.188","article-title":"Augmented expression of MYC and\/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study","volume":"113","author":"Wang","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0450","article-title":"Subgrouping of unfavorable histology neuroblastomas with immunohistochemistry toward precision prognosis and therapy stratification","volume":"3","author":"Ikegaki","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0455","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/cjp2.338","article-title":"Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements","volume":"9","author":"Yu","year":"2023","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.annpat.2025.06.025_bib0460","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0000000000001322","article-title":"Immunohistochemistry for ATRX can miss ATRX mutations: lessons from neuroblastoma","volume":"43","author":"Chami","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0465","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.annpat.2025.06.025_bib0470","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/gcc.22826","article-title":"Adult-onset neuroblastoma: report of seven cases with molecular genetic characterization","volume":"59","author":"Duan","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0475","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/cas.15363","article-title":"Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics","volume":"113","author":"van\u00a0Gerven","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.annpat.2025.06.025_bib0480","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.sempedsurg.2011.10.009","article-title":"Neuroblastoma","volume":"21","author":"Davidoff","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.annpat.2025.06.025_bib0485","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.bjc.6605014","article-title":"International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee","volume":"100","author":"Ambros","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0490","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/onc.2015.200","article-title":"Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors","volume":"35","author":"Berbegall","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.annpat.2025.06.025_bib0495","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41416-018-0098-6","article-title":"Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study","volume":"118","author":"Berbegall","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0500","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0215(19960422)69:2<73::AID-IJC1>3.0.CO;2-S","article-title":"Clinical relevance of loss heterozygosity of the short arm of chromosome 1\u00a0in neuroblastoma: a single-institution study","volume":"69","author":"Schleiermacher","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0505","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1158\/0008-5472.CAN-08-4419","article-title":"Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients","volume":"69","author":"Passoni","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.annpat.2025.06.025_bib0510","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ajpath.2015.10.016","article-title":"Mutation-independent activation of the anaplastic lymphoma kinase in neuroblastoma","volume":"186","author":"Regairaz","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0515","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s10147-020-01773-z","article-title":"TERT promotor region rearrangements analyzed in high-risk neuroblastomas by FISH method and whole genome sequencing","volume":"25","author":"Kawashima","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0520","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ejca.2010.10.022","article-title":"Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project","volume":"47","author":"Moroz","year":"2011","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.annpat.2025.06.025_bib0525","first-page":"537","article-title":"Neuroblastoma in situ","volume":"32","author":"Hasegawa","year":"1982","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.annpat.2025.06.025_bib0530","first-page":"1089","article-title":"In situ neuroblastomas: a contribution to the natural history of neural crest tumors","volume":"43","author":"Beckwith","year":"1963","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0535","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/jog.15968","article-title":"Congenital metastatic neuroblastoma with placental involvement as a rare cause of non-immune fetal hydrops","volume":"50","author":"Campillo-Ajenjo","year":"2024","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.annpat.2025.06.025_bib0540","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1097-0142(19970715)80:2<304::AID-CNCR19>3.0.CO;2-Y","article-title":"Prenatally diagnosed neuroblastoma","volume":"80","author":"Acharya","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0545","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15513810701696890","article-title":"Fetal and neonatal neuroblastoma: retrospective review of 271\u00a0cases","volume":"26","author":"Isaacs","year":"2007","journal-title":"Fetal Pediatr Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0550","doi-asserted-by":"crossref","first-page":"e31074","DOI":"10.1002\/pbc.31074","article-title":"Adolescent- and adult-onset neuroblastic tumor: a retrospective multicenter observational study of patients diagnosed in France between 2000\u00a0and 2020","volume":"71","author":"Magnier","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0555","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pbc.20859","article-title":"Neuroblastoma in adults: incidence and survival analysis based on SEER data","volume":"49","author":"Esiashvili","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.annpat.2025.06.025_bib0560","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1309\/AJCPN76VTIGWPOAG","article-title":"Composite pheochromocytoma: a clinicopathologic and molecular comparison with ordinary pheochromocytoma and neuroblastoma","volume":"132","author":"Comstock","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0565","first-page":"120","article-title":"Divergent differentiation in neuroendocrine tumors of the adrenal gland","volume":"17","author":"Tischler","year":"2000","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0570","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ajcp\/102.2.163","article-title":"Immunohistochemical detection of neuroblastomatous foci in composite adrenal pheochromocytoma-neuroblastoma","volume":"102","author":"Franquemont","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.annpat.2025.06.025_bib0575","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.5489\/cuaj.1160","article-title":"Composite paraganglioma-ganglioneuroma of the urinary bladder: a rare neoplasm causing hemodynamic crisis at tumour resection","volume":"3","author":"Chen","year":"2009","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.annpat.2025.06.025_bib0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1746-1596-8-63","article-title":"Retroperitoneal composite pheochromocytoma-ganglioneuroma: a case report and review of literature","volume":"8","author":"Hu","year":"2013","journal-title":"Diagn Pathol"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649825001518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649825001518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:41:11Z","timestamp":1777725671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649825001518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0242649825001518"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2025.06.025","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tour d\u2019horizon actualis\u00e9 de la pathologie des tumeurs neuroblastiques p\u00e9riph\u00e9riques","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2025.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}